WordNet

a substance that exerts some force or effect
a businessman who buys or sells for another in exchange for a commission (同)factor, broker
any agent or representative of a federal agency or bureau (同)federal agent
a representative who acts on behalf of other persons or organizations
an active and efficient cause; capable of producing a certain effect; "their research uncovered new disease agents"
how long something has existed; "it was replaced because of its age"
a time of life (usually defined in years) at which some particular qualification or power arises; "she was now of school age"; "tall for his eld" (同)eld
begin to seem older; get older; "The death of his wife caused him to age fast"
make older; "The death of his child aged him tremendously"
the formation of new blood vessels

PrepTutorEJDIC

『代理人』;周旋人 / 働き(作用)を起こすもの;作用物,薬剤 / (政府機関,特にFBI,CIAなどの)部員,機関員
〈U〉(一般に)『年齢』,寿命;〈C〉(個々の)『年齢』,年 / 〈U〉成年(おとなとしての資格・権利を得る年齢;通例18または21歳) / 〈U〉『老齢』;《集合的に》老人たち / 〈U〉(人生の)『一時期』;〈C〉世代(generation) / 〈U〉〈C〉《しばしばA-》(歴史上の)『時代』 / 〈C〉《話》長い間 / 年をとる,ふける;〈物が〉古くなる / 〈年〉'を'とらせる;〈物〉'を'古びさせる

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 血管新生阻害剤の概要 overview of angiogenesis inhibitors
2. 難治性狭心症マネージメントのための血管新生療法 therapeutic angiogenesis for management of refractory angina
3. ER／PR陰性、HER2陰性（トリプルネガティブ）乳癌の疫学、危険因子および臨床的アプローチ epidemiology risk factors and the clinical approach to er pr negative her2 negative triple negative breast cancer
4. 上皮性卵巣癌、卵管癌、または腹膜癌における血管新生阻害剤の作用 the role of angiogenesis inhibitors in epithelial carcinoma of the ovary fallopian tube or peritoneum
5. 下肢の慢性重症下肢虚血の治療 treatment of chronic lower extremity critical limb ischemia

Anticancer effects of ginsenoside Rk3 on non-small cell lung cancer cells: in vitro and in vivo.

Duan Z1, Deng J, Dong Y, Zhu C, Li W, Fan D.
Food & function.Food Funct.2017 Oct 18;8(10):3723-3736. doi: 10.1039/c7fo00385d.
PMID 28949353

Molecular targets and anticancer potential of sanguinarine-a benzophenanthridine alkaloid.

Galadari S1, Rahman A2, Pallichankandy S3, Thayyullathil F4.
Phytomedicine : international journal of phytotherapy and phytopharmacology.Phytomedicine.2017 Oct 15;34:143-153. doi: 10.1016/j.phymed.2017.08.006. Epub 2017 Aug 8.
PMID 28899497

Abdul Rahim SA1, Dirkse A1,2, Oudin A1, Schuster A1, Bohler J1, Barthelemy V1, Muller A3, Vallar L3, Janji B4, Golebiewska A1, Niclou SP1,5.
British journal of cancer.Br J Cancer.2017 Sep 5;117(6):813-825. doi: 10.1038/bjc.2017.263. Epub 2017 Aug 10.
PMID 28797031

Peking University - Juntendo University Joint Symposium on Brain and Skin Diseases

Anti-tumor Activity of the Novel Hexahydrocannabinol Analog LYR-8 in Human Colorectal Tumor Xenograft Is Mediated through the Inhibition of Akt and Hypoxia-Inducible Factor-1α Activation

ZD1839 (Gefitinib, 'Iressa'), an epidermal growth factor receptor-tyrosine kinase inhibitor, enhances the anti-cancer effects of TRAIL in human esophageal squamous cell carcinoma